Clinical Trial Update: Prospective Cohort of Locally Advanced and Metastatic Non-Small Cell Lung Cancer Patients With Activating EGFR Mutations

View source ↗

Summary

A prospective cohort study in locally advanced and metastatic non-small cell lung cancer patients with activating EGFR mutations is currently active but not rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• TAGRISSO (osimertinib)

Snippet

Sponsor: AstraZeneca | Conditions: Non Small Cell Lung Cancer | Status: ACTIVE_NOT_RECRUITING